I have a survey question for the group as background for research. If you would, please respond off the list. If there are enough responses I can compile for the group.
1.) Do you use nebulizers or MDIs(+spacer) to treat acute pediatric asthma exacerbations? (% of each if you use both)
2.) If you use both, how do you decide? (age, severity of illness)
3.) What practice setting? (peds or general ED, academic or private)
4.) Do you have an asthma protocol/pathway in the ED? (if so, would you be willing to share it?)
5.) If you have a protocol/pathway, does it dictate whether you use an MDI or nebulizer, or does it leave it up to choice?
There is a great deal of literature from other countries regarding the MDI/nebulizer controversy, including surveys of use and barriers to change, pre and post education/intervention surveys, and economic analyses. I have not been able to find as much in the US literature. The only published survey I found was from 2001 (Tien et al, ArchPediatr Adolesc Med). If anyone knows of any more recent published or unpublished survey data I would appreciate it.
Thanks for your help!
Matt Wilkinson, MD
UTSW - Austin PEM Fellowship
Dell Children's Medical Center of Central Texas
[log in to unmask]
For more information, send mail to [log in to unmask] with the message: info PED-EM-L
The URL for the PED-EM-L Web Page is: